XBiotech Inc.XBITNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+12.6%
5Y CAGR+14.3%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+12.6%/yr
vs +15.9%/yr prior
5Y CAGR
+14.3%/yr
Consistent
Acceleration
-3.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$54.00M+27.1%
2024$42.47M+13.2%
2023$37.51M-0.9%
2022$37.85M+0.5%
2021$37.66M+35.8%
2020$27.73M-4.0%
2019$28.87M+37.5%
2018$20.99M-38.4%
2017$34.06M-35.4%
2016$52.76M-